Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-opioid peptides for analgesia

J Chrubasik1, S Chrubasik, E Martin

  • 1Department of Anesthesiology, University Hospital, Heidelberg, Germany.

Acta Neurobiologiae Experimentalis
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ketamine attenuates endotoxin-induced leukocyte adherence in rat mesenteric venules.

Critical care medicine·1995
Same author

Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1.

Blood·1995
Same author

Lignocaine metabolite formation: an indicator for liver dysfunction and predictor of survival in surgical intensive care patients.

Anaesthesia·1995
Same author

Propofol-induced alterations in the microcirculation of hamster striated muscle.

British journal of anaesthesia·1995
Same author

Testing the porphyrinogenicity of propofol in a primed rat model.

British journal of anaesthesia·1995
Same author

Physician-assisted suicide, a symposium. Death made too easy or an act of profound compassion?

Rhode Island medicine·1995
Same journal

Chronic pantoprazole exposure induces behavioral deficits and region‑specific molecular changes in the rat motor cortex and cerebellum.

Acta neurobiologiae experimentalis·2026
Same journal

Modulation of electrically evoked hippocampal epileptiform activity by exogenous orexins in the rat CA1 field.

Acta neurobiologiae experimentalis·2026
Same journal

The effect of clozapine and GABA<sub>A</sub> receptor drugs on scopolamine‑induced amnesia in male mice.

Acta neurobiologiae experimentalis·2026
Same journal

<i>LRRK2</i> mutations: at the crossroads of dopamine, iron, and calcium imbalance in Parkinson's disease.

Acta neurobiologiae experimentalis·2026
Same journal

Effects of transcranial direct current stimulation in multiple sclerosis: Recent findings of clinical studies and animal models.

Acta neurobiologiae experimentalis·2026
Same journal

Microglia up‑regulate thromboxane A2 synthesis genes in response to C6 glioma‑conditioned medium.

Acta neurobiologiae experimentalis·2026
See all related articles

Spinal somatostatin is the only peptide candidate that effectively blocks pain transmission. Other peptides like calcitonin have limited effects, and current animal pain tests are inadequate for neuropeptide research.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Spinal peptides are investigated for their role in pain relief (analgesia).
  • Several peptide candidates have been proposed, but their efficacy and mechanisms remain unclear.
  • Existing animal models for pain testing may not accurately reflect human responses to neuropeptides.

Purpose of the Study:

  • To evaluate the analgesic potential of various spinal peptides.
  • To determine the suitability of current animal models for assessing neuropeptide efficacy in pain management.
  • To identify reliable spinal peptide candidates for pain relief.

Main Methods:

  • Review of existing literature on spinal peptides and analgesia.
  • Analysis of the criteria for classifying a substance as an analgesic.

Related Experiment Videos

  • Evaluation of the appropriateness of rodent withdrawal reflex and hot plate tests for neuropeptide research.

    • Main Results:

    • Somatostatin is identified as the only spinal peptide that specifically blocks pain signal transmission.
    • Calcitonin may reduce opioid dosage in specific cases but does not alleviate acute pain.
    • The analgesic effects of ACTH, CRF, CCK-8, vasopressin, and neurotensin are inconclusive or require further investigation.
    • Current animal pain tests are deemed inappropriate for neuropeptide evaluation due to contradictory findings and poor predictive value for human analgesia.

    Conclusions:

    • Somatostatin demonstrates significant potential as a spinal analgesic agent.
    • Rodent pain tests are inadequate for assessing neuropeptide analgesia and do not meet international guidelines for human benefit.
    • Further research is needed to establish the role and therapeutic potential of other spinal peptides in pain management.